Thomas Stankovich Re Shape Lifesciences Inc. (RSLS) insider trading activity

Thomas Stankovich is Chief Financial Officer of ReShape Lifesciences Inc.. Currently has a direct ownership of 22,949 shares of RSLS, which is worth approximately $4,360. The most recent transaction as insider was on Oct 25, 2023, when has been sold 131 shares (Common Stock, $0.001 par value per share) at a price of $0.27 per share, resulting in proceeds of $35. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.9K

0% 3M change

2.3% 12M change

Total Value Held $4,360

THOMAS STANKOVICH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 25 2023	SELL Open market or private sale	$35 $0.27 p/Share	131 Reduced 0.57%	22,949 Common Stock, $0.001 p...
Oct 11 2023	SELL Open market or private sale	$36 $0.93 p/Share	39 Reduced 0.17%	23,080 Common Stock, $0.001 p...
Sep 01 2023	SELL Open market or private sale	$105 $0.89 p/Share	118 Reduced 0.51%	23,119 Common Stock, $0.001 p...
Aug 24 2023	SELL Open market or private sale	$55 $1.42 p/Share	39 Reduced 0.17%	23,237 Common Stock, $0.001 p...
Aug 04 2023	SELL Open market or private sale	$154 $1.43 p/Share	108 Reduced 0.46%	23,276 Common Stock, $0.001 p...
Jul 06 2023	SELL Open market or private sale	$155 $1.47 p/Share	106 Reduced 0.45%	23,384 Common Stock, $0.001 p...
Jun 30 2023	BUY Open market or private purchase	$26,907 $1.52 p/Share	17,702 Added 42.97%	23,490 Common Stock, $0.001 p...

May 31 2023	SELL Open market or private sale	$236 $2.41 p/Share	98 Reduced 1.66%	5,788 Common Stock, $0.001 p...
Apr 30 2023	SELL Open market or private sale	$226 $2.36 p/Share	96 Reduced 1.6%	5,886 Common Stock, $0.001 p...
Mar 31 2023	SELL Open market or private sale	$283 $2.6 p/Share	109 Reduced 1.79%	5,982 Common Stock, $0.001 p...
Feb 28 2023	SELL Open market or private sale	$437 $4.25 p/Share	103 Reduced 1.66%	6,091 Common Stock, $0.001 p...
Feb 02 2023	SELL Open market or private sale	$2,086 $13.29 p/Share	157 Reduced 2.47%	6,194 Common Stock, $0.001 p...
Jan 24 2023	SELL Open market or private sale	$1,183 $7.49 p/Share	158 Reduced 2.43%	6,351 Common Stock, $0.001 p...
Dec 01 2022	SELL Open market or private sale	$1,103 $0.15 p/Share	7,357 Reduced 2.21%	325,404 Common Stock, $0.001 p...
Nov 28 2022	SELL Open market or private sale	$62,008 $0.17 p/Share	364,756 Reduced 52.29%	332,761 Common Stock, $0.001 p...
Nov 17 2022	BUY Grant, award, or other acquisition	-	364,756 Added 34.34%	697,517 Common Stock, $0.001 p...
Nov 04 2022	SELL Open market or private sale	$2,266 $0.27 p/Share	8,393 Reduced 2.46%	332,761 Common Stock, $0.001 p...
Oct 04 2022	SELL Open market or private sale	$2,322 $0.28 p/Share	8,293 Reduced 2.39%	338,670 Common Stock, $0.001 p...
Sep 06 2022	SELL Open market or private sale	$1,883 $0.39 p/Share	4,828 Reduced 1.37%	346,963 Common Stock, $0.001 p...
Aug 05 2022	SELL Open market or private sale	$2,222 $0.47 p/Share	4,728 Reduced 1.33%	351,791 Common Stock, $0.001 p...
Jul 01 2022	SELL Open market or private sale	$2,547 $0.55 p/Share	4,630 Reduced 1.28%	356,519 Common Stock, $0.001 p...
Jun 01 2022	SELL Open market or private sale	$4,299 $0.96 p/Share	4,478 Reduced 1.22%	361,149 Common Stock, $0.001 p...
May 31 2022	BUY Open market or private purchase	$18,200 $0.91 p/Share	20,000 Added 5.19%	365,627 Common Stock, $0.001 p...
May 05 2022	SELL Open market or private sale	$3,487 $0.77 p/Share	4,529 Reduced 1.29%	345,627 Common Stock, $0.001 p...
Apr 01 2022	SELL Open market or private sale	$5,693 $1.13 p/Share	5,038 Reduced 1.42%	350,156 Common Stock, $0.001 p...

Also insider at

RSLS

ReShape Weightloss Inc.

Chief Financial Officer